Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207791 · ClinicalTrials.gov registry record · NA
Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments
A NA study of Drug Abuse, sponsored by University of New Mexi.
- Completed
- Registry status
- NA
- Development phase
- 1,285
- Enrollment target
- 7
- Study locations
NCT01207791: Completed NA study of Drug Abuse, sponsored by University of New Mexi.
NCT01207791 is a NA study of Drug Abuse that has completed, run by University of New Mexi. The registered enrollment target is 1,285 participants, above the 265-participant average among 21 other Drug Abuse trials with a reported enrollment target (385% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01207791, a NA study of Drug Abuse, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,285 participants
- Enrollment target
- 7
- Study locations
Study Summary
Misuse of drugs and alcohol has a tremendous impact on individual health and on society, in terms of both human suffering and economic cost. Most substance abusers never seek specialty addiction treatment, but a large percentage of them receives some form of medical care, frequently in emergency room settings. There is considerable evidence showing that Screening, Brief Intervention, Referral, and Treatment (SBIRT) interventions in medical settings result in decreased drinking and alcohol-related problems among those with alcohol abuse or dependence. However, there are few studies using these models focusing on drug users. Although drug users are seen in large numbers in emergency departments, there have been no randomized controlled trials of SBIRT models for drug users presenting in Emergency Departments (EDs). This study is designed to assess the effects of Assessment, Referral, and a Brief Intervention on substance use of individuals screening positive for drug use during a medical ED visit. The Southwest Node of the NIDA Clinical Trials Network, located at UNM CASAA, is taking the lead on this study. Six sites across the country will participate in this study, including the ED of UNM Hospital. A total of 1285 ED patients who screen positive for current drug use problems will be randomly assigned to receive 1) minimal screening only, 2) assessment of substance use and referral to treatment, or 3) assessment and referral combined with a 30-minute counseling session (Brief Intervention) and two follow-up telephone counseling sessions. Outcomes will be assessed at 3, 6, and 12 months after the ED visit. We hypothesize that those who receive the Brief Intervention will have the least drug use at follow-up, that those who receive minimal screening only (the usual current practice) will have the most drug use, and that those receiving assessment and referral without the Brief intervention will have intermediate outcomes.
Primary Outcome
Assessed by Time-line Follow-back method
Conditions Studied
Interventions
- BEHAVIORAL assessment
- BEHAVIORAL Brief intervention
- BEHAVIORAL screening
- BEHAVIORAL referral
- BEHAVIORAL booster sessions
Study Locations (7)
Florida
- Jackson Memorial Hospital - Miami
Massachusetts
- Massachusetts General Hospital - Boston
New Mexico
- University of New Mexico Hospital - Albuquerque
New York
- Belleview Hospital - New York
Ohio
- University of Cincinnati Hospital - Cincinnati
Washington
- University of Washington - Seattle
West Virginia
- West Virginia University Hospital - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,285 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01207791 record still lists
NCT01207791 is an interventional study that assigns participants to a tested intervention. Its 1,285 participants enrollment target places it among the larger protocols in the corpus, above the 265-participant average among 21 other Drug Abuse trials with a reported enrollment target (385% higher).
The record links to 1 condition, with Drug Abuse appearing as the primary indexed condition, and to 5 interventions - of which assessment is the first listed.
NCT01207791 lists 7 locations in 7 states (Florida, Massachusetts, New Mexico).
Frequently Asked Questions
What is clinical trial NCT01207791 about?
NCT01207791 is a clinical study titled "Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments". Misuse of drugs and alcohol has a tremendous impact on individual health and on society, in terms of both human suffering and economic cost. Most substance abusers never seek specialty addiction treatment, but a large percentage of them receives some form of medical care, frequently in emergency roo...
What is the current status of trial NCT01207791?
This trial is currently completed. It is a NA study. The enrollment target is 1,285 participants. The study started on 2010-10. Estimated completion is 2013-03.
What conditions does trial NCT01207791 study?
This clinical trial studies the following conditions: Drug Abuse.
What interventions are being tested in trial NCT01207791?
The interventions under investigation include: assessment (BEHAVIORAL), Brief intervention (BEHAVIORAL), screening (BEHAVIORAL), referral (BEHAVIORAL), booster sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01207791?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01207791 being conducted?
This trial has 7 study locations across Florida, Massachusetts, New Mexico, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01207791's enrollment target sits among peer trials
1,285 1st of 21 higher than 21 of 21 other Drug Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wakaya: Rising Up for Choctaw Youth Health
RECRUITING · NA
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
RECRUITING · NA
-
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Adolescent Family-Based Alcohol Prevention
COMPLETED · NA
-
Computerized Brief Intervention vs. Delayed Computerized Brief Intervention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia